News Focus
News Focus
Followers 11
Posts 1963
Boards Moderated 0
Alias Born 04/16/2024

Re: None

Tuesday, 11/05/2024 8:30:55 AM

Tuesday, November 05, 2024 8:30:55 AM

Post# of 1747
Awesome story - they will rival Mirati in KRAS mutated CRC and combination options are a plus. Pfizer really wants this compound, will freshen up the space and hopefully make it cheaper too.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRDF News